ArticleOncotarget2016

Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells.

Maria C Palanca-Wessels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.